drugset / Trial / NCT01074294
Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
This study tests the effects of an investigational antipsychotic drug (called OPC-34712) in adults with attention deficit hyperactivity disorder (ADHD) when taken with an approved stimulant medication to explore a possible impact on sleep, quality of life and cognitive function.
Timeline
- Start
- 2010-03-16
- Primary completion
- 2011-06-20
- Completion
- 2011-06-20
Outcome
Missed primary endpoint
registry p = 0.5845; Mean Difference (Final Values) 0.69 (95% CI -1.80 to 3.19) NCT01074294 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OPDC-34712 | Unknown | 2 mg | Oral |
| Background | Dexmethylphenidate hydrochloride (HCL) | Unknown | — | — |
| Background | Lisdexamfetamine Dimesylate | Small molecule | — | — |
| Background | Methylphenidate | Small molecule | — | — |
| Background | mixed amphetamine salts | Unknown | — | — |